There are 2789 resources available
Optimal selection of patients with untreated advanced renal carcinoma for combination and monotherapy regimens: Agents, combinations and emerging biomarkers
Presenter: Jens Bedke
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Optimal selection of patients with untreated advanced hepatocellular cancer for combination and monotherapy regimens: Agents, combinations and emerging biomarkers
Presenter: Masafumi Ikeda
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Optimal selection of patients with platinum-pretreated advanced endometrial carcinoma for combination and monotherapy regimens: Agents, combinations and emerging biomarkers
Presenter: Cristiana Sessa
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Proactive and reactive strategies for improving patient compliance and safety of VEGFR-TKI/immune checkpoint inhibitor combinations
Presenter: Giuseppe Procopio
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Full session recording
Presenter: Keith Kerr
Session: Janssen - Expanding horizons for the targeted management of EGFR-Positive NSCLC
Resources:
Webcast
Live Q&A
Presenter: David Planchard, Keith M. Kerr, Alexander Spira, Johan F. Vansteenkiste
Session: Janssen - Expanding horizons for the targeted management of EGFR-Positive NSCLC
Resources:
Webcast
Advanced prostate cancer: Lessons learned from the last decade
Presenter: Johann de Bono
Session: Janssen - A Decade’s Perspective on Advances in Prostate Cancer
Resources:
Webcast
Optimising the management of patients with advanced prostate cancer: Key questions in 2021
Presenter: Steven Joniau
Session: Janssen - A Decade’s Perspective on Advances in Prostate Cancer
Resources:
Webcast
Welcome and introduction
Presenter: Laura-Maria Krabbe
Session: Janssen - A Decade’s Perspective on Advances in Prostate Cancer
Resources:
Webcast
Full session recording
Presenter: Nicoletta Colombo
Session: AstraZeneca - Redefining long-term outcomes in newly diagnosed advanced ovarian cancer: Expert perspectives on integrating personalized medicine
Resources:
Webcast